新辅助化疗也开始显示出良好疗效。
新辅助化疗并未增加手术并发症。
Complications of surgery were not increased by neoadjuvant chemotherapy.
总之，这个患者可以进行辅助或新辅助化疗。
In summary, this patient can be treated with adjuvant or neoadjuvant chemotherapy.
目的：验证可手术胰腺癌新辅助化疗的安全性。
Purpose: To test the safety of neoadjuvant chemotherapy for resectable pancreatic cancer.
目的探讨新辅助化疗在晚期乳腺癌治疗中的效果。
Objective To study the clinical effect of neoadjuvant chemotherapy on advanced breast cancer.
目的观察新辅助化疗对局部晚期宫颈癌的临床疗效。
Objective To study the clinical effects of new adjuvant chemotherapy on locally advanced carcinoma of the cervix.
目的：探讨新辅助化疗在老年乳腺癌患者治疗中的意义。
Objective: To evaluate the significance of neoadjuvant chemotherapy in elder breast cancer patients.
现就新辅助化疗在乳腺癌治疗中的现状及展望作一综述。
This review presents the present state and future prospect of neoadjuvant chemotherapy for advanced breast cancer.
研究人员对接受新辅助化疗的II期乳腺癌患者进行了研究。
To investigate, the researchers studied stage II and II breast cancer patients who were receiving neoadjuvant chemotherapy.
目的研究新辅助化疗在中晚期乳腺癌保乳治疗中的应用价值。
Objective To study the value of pre-operative chemotherapy combined with breast conservation surgery for the treatment of middle-advanced breast cancer.
目的评价保肢手术结合新辅助化疗治疗肢体骨肉瘤的临床疗效。
Objecttive To evaluate the clinical effectiveness of limb salvage surgery combined with new adjuvant chemotherapy for extremity osteosarcoma.
目的：对36例采用新辅助化疗的骨肉瘤患者进行回顾性分析。
Objective:Making Retrospective a na lyses of the osteosarcoma patients adopting new adjuvant chemotherapy in36ca ses.
该文主要对近年来新辅助化疗在胃癌治疗中的现状进行了综述。
The present status of neoadjuvant chemotherapy for the treatment of gastric cancer was reviewed in this article.
观察和探讨CEF方案在乳腺癌新辅助化疗应用中的临床疗效。
Objective To observe and discuss the clinical effect of CEF new accessorial chemotherapy project in treating breast cancer.
目的：探讨乳腺癌病人新辅助化疗后前哨淋巴结活检的可行性。
Objective: To study the feasibility of sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy for breast cancer.
前言： 目的：探讨新辅助化疗在局部晚期乳腺癌治疗中的应用。
Objective: To evaluate the effect of neoadjuvant chemotherapy in the treatment of locally advanced breast cancer.
在确认组(？)，198名中的165名患者接受了新辅助化疗。
In the validation group, 165 of 198 patients received all chemotherapy as neoadjuvant treatment.
结论：紫杉醇联合顺铂新辅助化疗方案治疗中晚期食管癌疗效显著。
Conclusion: the combination of paclitaxel and cisplatin was an effective regimen as neoadjuvant chemotherapy for LAEC.
医生认为II I期结肠癌新辅助化疗的患者年龄和伴随疾病重要吗？
Adjuvant Chemotherapy for Stage III Colon Cancer: Do Physicians Agree About the Importance of Patient age and Comorbidity?
结论术前新辅助化疗可提高食管癌手术的切除率并不增加术后并发症。
Conclusion Patients of esophageal carcinoma, neoadjuvant chemotherapy can increased the resectability rate, meanwhile cannot increase postoperative complications and mortality.
目的探讨术前新辅助化疗对乳腺癌的疗效及提高患者术后生存率的作用。
To explore the effect of new auxiliary chemotherapy before operation on treating local mammary cancer of late stage and prolonging the life of the cancer patients.
新辅助化疗可以减小肿瘤负荷，降低临床病期，提高肿瘤的手术切除率。
Neoadjuvant chemotherapy can minish burthen of tumor and lower the clinical stage, and increase resection rate of cancer.
目的：探讨乳腺癌新辅助化疗对耐药基因mdr1和MRP表达的影响。
AIM: To investigate the expression of drug resistance genes, MDR1 and MRP, in patients with primary breast cancer after neoadjuvant chemotherapy.
目的了解心理行为干预对乳腺癌新辅助化疗患者情绪及免疫功能的影响。
Objective To learn about the influence of psychological and behavioral intervention on the emotion and immune function of patients undergoing breast cancer neo-adjuvant chemotherapy.
方法：回顾性分析32例局部晚期乳腺癌患者进行新辅助化疗的临床资料。
Methods: 32 patients with locally advanced breast cancer treated by neoadjuvant chemotherapy were reviewed retrospectively.
结论：新辅助化疗能诱导人体乳腺癌肿瘤细胞发生凋亡，并能抑制其增殖。
Conclusions: Neoadjuvant chemotherapy can induce tumor cell apoptosis and inhibit tumor cell proliferation in patients with breast cancer.
新辅助化疗能减少肿瘤负荷，降低原发肿瘤分期，增加手术切除的可能性。
Neoadjuvant chemotherapy can reduce tumor loading, degrade the staging, afford operation possibility.
目的：观察中医扶正培本治疗对乳腺癌新辅助化疗患者细胞免疫功能的影响。
Objective:To observe the effects of neoadjuvant chemotherapy and neoadjuvant chemotherapy plus Shenqi Fuzheng Injection on cell immunofunction in patients with breast cancer.
目的评价CEF方案新辅助化疗治疗局部晚期乳腺癌的临床疗效和毒性反应。
Objective to evaluate the clinical efficacy and toxicity of CEF as the neoadjuvant chemotherapy regimen in the treatment of locally advanced breast cancer (LABC).
乳腺癌术前化疗即新辅助化疗，使局部进展期乳腺癌的治疗取得了重大进展。
Nowadays, neoadjuvant chemotherapy, which is raised by clinic, made a big breakthrough in breast cancer partial treatment progression.
应用推荐